Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Juvenile Idiopathic Arthritis (sJIA)”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Large-scale testing (Phase 3)Study completedNCT00144612
What this trial is testing

Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 60
Large-scale testing (Phase 3)Study completedNCT02334748
What this trial is testing

Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies

Who this might be right for
Systemic Juvenile Idiopathic ArthritisHereditary Periodic Fevers
Novartis Pharmaceuticals 31
Not applicableStudy completedNCT03932344
What this trial is testing

Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Still Disease, Juvenile Onset
Swedish Orphan Biovitrum 306
Early research (Phase 1)Study completedNCT01803321
What this trial is testing

Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Regeneron Pharmaceuticals 24
Testing effectiveness (Phase 2)Looking for participantsNCT02991469
What this trial is testing

A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)

Who this might be right for
Juvenile Idiopathic Arthritis
Sanofi 51
Not applicableLooking for participantsNCT03510442
What this trial is testing

Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions

Who this might be right for
Still's Disease, Adult-OnsetSystemic InflammationArthritis+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 2,000
Testing effectiveness (Phase 2)Study completedNCT00534495
What this trial is testing

Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults

Who this might be right for
Juvenile Idiopathic Arthritis
Montefiore Medical Center 71
Early research (Phase 1)Study completedNCT02165345
What this trial is testing

Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 82
Large-scale testing (Phase 3)Study completedNCT00891046
What this trial is testing

An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 270
Large-scale testing (Phase 3)WithdrawnNCT01676948
What this trial is testing

An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00889863
What this trial is testing

Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis With Active Flare
Novartis Pharmaceuticals 177
Large-scale testing (Phase 3)Study completedNCT00277251
What this trial is testing

Alendronate Osteoporosis Study

Who this might be right for
Glucocorticoid-Associated Osteopenia and Osteoporosis
Boston Children's Hospital 20
Large-scale testing (Phase 3)Ended earlyNCT00078806
What this trial is testing

Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Rheumatoid Arthritis
Amgen 19
Large-scale testing (Phase 3)Ended earlyNCT03265132
What this trial is testing

Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)

Who this might be right for
Still's Disease, Adult-OnsetStill's Disease, Juvenile-Onset
Swedish Orphan Biovitrum 13
Large-scale testing (Phase 3)Study completedNCT00144599
What this trial is testing

Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 56
Not applicableNot Yet RecruitingNCT06718049
What this trial is testing

Role of Interleukin 18 (IL-18) and Interleukin 18 Binding Protein (IL-18BP) in the Diagnostic Work-up of Systemic Juvenile Idiopathic Arthritis and Autoinflammatory Diseases: Possible Biomarkers in the Differential Diagnosis of Other Febrile Diseases

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (sJIA)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 9
Not applicableLooking for participantsNCT06838143
What this trial is testing

Ilaris NIS in Korea

Who this might be right for
Hereditary Periodic Fever SyndromesCryopyrin-associated Periodic Syndromes (CAPS)Colchicine Resistance Familial Mediterranean Fever (crFMF)+3 more
Novartis Pharmaceuticals 25
Large-scale testing (Phase 3)Study completedNCT02396212
What this trial is testing

Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 19
Large-scale testing (Phase 3)Study completedNCT00144664
What this trial is testing

Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 19
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Load More Results